, rhinitis (6), or urticaria ('). Food hypersensitivity can also manifest as arthritis (8, 9) and migraine (10, 11) . Histamine from gut mast cells could bind to sensory nerves to produce an afferent signal, which could be rerouted via the central nervous system to another site, as depicted in Figure 1 (12) (13 (17, 18) . This type of switching might be termed "immunogenic switching." Neurogenic switching may play a role in multiple chemical sensitivity syndrome (19) (20) (21) , which is thought to be mediated by neurogenic inflammation (22) (23) , migraine headache (24, 25) , and fibromyalgia (26) be an acquired neuronal pathway that shunts inflammatory stimuli to the joints, cerebral vasculature, or muscles, respectively. Then, inflammatory stimuli arising from allergens, chemical irritants, or infectious agents could lead to a flare in inflammation at the diseased site. Emotional stress might also lead to neuronal signals that could result in inflammation at susceptible sites.
To summarize, it has been pointed out that the multiple organ system involvement that has been so problematic in understanding chemical sensitivity also occurs in allergy. A single mechanism may underlie this switching of the site of inflammation in both allergy and chemical sensitivity. It is hypothesized that neurogenic switching is one possible mechanism by which stimulation of inflammation at one site can lead to inflammation at another (Fig. 1 ). An exposure to either an allergen or chemical irritant at one site leads to a sensory nerve impulse. For allergens, mast cell degranulation leads to the release of histamine and other mediators, and histamine binds receptors on sensory nerves. For chemical irritants, receptors on peripheral nerves are directly triggered. When the impulse reaches the central nervous system, it is redirected to another peripheral location, leading to the release of substance P and other neuropeptides, producing inflammation at the second site.
An alternative hypothesis is that immunogenic switching occurs, with the release of cytokines which act on distant cells. There are several differences expected between neurogenic switching and immunogenic switching. The time required for the onset of neurogenic switching depends on nerve conduction velocity, while immunogenic switching depends on circulation time and diffusion times in tissues. Neurogenic switching would directly target a particular organ in a repetitive pattern, while immunogenic switching might have a more diffuse effect. The mechanism by which the site of inflammation is shifted in both allergy and chemical sensitivity can be determined experimentally, both in controlled challenges in human subjects and experimental models. Such a program could further our understanding of these conditions while leading to improvements in diagnosis and treatment.
